Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BIA weighs two strategies for new leadership, will announce soon

This article was originally published in Scrip

Executive Summary

As its interim CEO Glyn Edwards accepts a third leadership position in industry in less than a year, the BIA is poised to announce a permanent leader after nearly six months in limbo. Mr Edwards, who today was unveiled as the new CEO of UK iminosugar specialist Summit (scripintelligence.com, 4 April 2012), told Scrip that the board and executive committee of the UK's BioIndustry Association (BIA) would be meeting shortly to decide on one of two broad alternatives after having received a variety of applications for its CEO position.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC016865

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel